Majority of people with ADHD in Ireland still thought to be untreated,...
In her debut blog, Poppy Ellis Logan summarises a longitudinal study which finds rates of ADHD prescription increased in Ireland between 2005 and 2015. The post Majority of people with ADHD in Ireland...
View ArticleLiving in anxious times? The rise of anxiety disorders in the UK
Alice Grishkov and Derek Tracy explore a recent paper, which finds that generalised anxiety disorder is on the rise in the UK, especially in young women. The post Living in anxious times? The rise of...
View ArticleLong-acting injectable antipsychotics: more effective than oral medications...
Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia. The post Long-acting...
View ArticleChoosing between antipsychotics to reduce the risk of breast cancer in women...
Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of...
View ArticleYouth mental health interventions: umbrella review presents efficacy and...
In his debut blog, Nick Meader tackles a huge umbrella review of youth mental health interventions, which presents the efficacy and acceptability of 72 different approaches to help children and young...
View ArticleTo stay on antipsychotics or not to stay on antipsychotics? A longstanding...
Joe Pierre considers a recent network meta-analysis on continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable. The...
View ArticleDo different groups of people with schizophrenia respond differently to...
Murtada Alsaif considers a systematic review and meta-analysis published in the Lancet Psychiatry exploring the response of different subgroups of patients with schizophrenia to different antipsychotic...
View ArticleUncertainties about stopping or reducing antipsychotics as shared by families
Amelia Talbot considers a qualitative study that explores family members’ perspectives on reducing or discontinuing antipsychotic medication. The post Uncertainties about stopping or reducing...
View ArticleOptimal antipsychotic dosing in first-episode schizophrenia: how much is too...
Joe Pierre reports on the first published study exploring the relationship between antipsychotic dose and risk of relapse in first episode schizophrenia, which suggests that standard antipsychotic...
View ArticlePredicting treatment-resistant psychosis using routine clinical measures
Lorna Staines summarises a recent study on predicting treatment-resistant psychosis, which suggests that future risk prediction efforts should seek to consider routinely collected data. The post...
View Article
